MAKO Mako Surgical Corp. (MM)

MAKO Surgical Corp. (Nasdaq:MAKO) announced today that the Company will host an event for research analysts and investors where surgeons will discuss their experience with MAKOplasty. This event will be held concurrent with the American Academy of Orthopaedic Surgeons 2012 Annual Meeting in San Francisco on Wednesday, February 8 at 6:00 pm Pacific Time.

Interested parties may access a live webcast by visiting MAKO's website at www.makosurgical.com under the Investor Relations section. A replay of the webcast will be available immediately after the conclusion of the presentation. Due to space constraints, in person attendance is limited and by invitation only.

About MAKO Surgical Corp. MAKO Surgical Corp. is a medical device company that markets its RIO® Robotic-Arm Interactive Orthopedic system, joint specific applications for the knee and hip, and proprietary RESTORIS® implants for orthopedic procedures called MAKOplasty®. The RIO is a surgeon-interactive tactile surgical platform that incorporates a robotic arm and patient-specific visualization technology, which enables precise, consistently reproducible bone resection for the accurate insertion and alignment of MAKO's RESTORIS implants. The MAKOplasty solution incorporates technologies enabled by an intellectual property portfolio including more than 300 U.S. and foreign, owned and licensed, patents and patent applications. Additional information can be found at www.makosurgical.com.

"MAKOplasty®," "RESTORIS®," "RIO®," as well as the "MAKO" logo, whether standing alone or in connection with the words "MAKO Surgical Corp." are trademarks of MAKO Surgical Corp.

CONTACT: Investors:
         MAKO Surgical Corp.
         954-628-1706
         investorrelations@makosurgical.com
         
         or
         
         Westwicke Partners
         Mark Klausner
         443-213-0500
         makosurgical@westwicke.com